Follow
Rick C. Betori
Rick C. Betori
Process Chemist, Corteva Agriscience
Verified email at corteva.com
Title
Cited by
Cited by
Year
Combined photoredox and carbene catalysis for the synthesis of ketones from carboxylic acids
AV Bay, KP Fitzpatrick, RC Betori, KA Scheidt
Angewandte Chemie 132 (23), 9228-9233, 2020
1692020
Heterogeneous catalysis for cross-coupling reactions: an underutilized powerful and sustainable tool in the fine chemical industry?
S Vásquez-Céspedes, RC Betori, MA Cismesia, JK Kirsch, Q Yang
Organic Process Research & Development 25 (4), 740-753, 2021
712021
Retracted: Combined Photoredox/Enzymatic C− H Benzylic Hydroxylations
RC Betori, CM May, KA Scheidt
Angewandte Chemie International Edition 58 (46), 16490-16494, 2019
642019
Reductive Arylation of Arylidene Malonates Using Photoredox Catalysis
RC Betori, KA Scheidt
ACS catalysis 9 (11), 10350-10357, 2019
572019
An enantioselective cross-dehydrogenative coupling catalysis approach to substituted tetrahydropyrans
A Lee, RC Betori, EA Crane, KA Scheidt
Journal of the American Chemical Society 140 (20), 6212-6216, 2018
542018
Precision therapeutic targeting of human cancer cell motility
L Xu, R Gordon, R Farmer, A Pattanayak, A Binkowski, X Huang, M Avram, ...
Nature communications 9 (1), 2454, 2018
362018
Reductive annulations of arylidene malonates with unsaturated electrophiles using photoredox/Lewis acid cooperative catalysis
RC Betori, BR McDonald, KA Scheidt
Chemical Science 10 (11), 3353-3359, 2019
322019
A biocatalytic route to highly enantioenriched β‐hydroxydioxinones
RC Betori, ER Miller, KA Scheidt
Advanced synthesis & catalysis 359 (7), 1131-1137, 2017
212017
Targeted covalent inhibition of telomerase
RC Betori, Y Liu, RK Mishra, SB Cohen, SJ Kron, KA Scheidt
ACS chemical biology 15 (3), 706-717, 2020
172020
A kinetics-based approach for the assignment of reactivity purge factors
RC Betori, JM Kallemeyn, DS Welch
Organic Process Research & Development 19 (11), 1517-1523, 2015
112015
Targeting telomerase reverse transcriptase with the covalent inhibitor NU-1 confers immunogenic radiation sensitization
Y Liu, RC Betori, J Pagacz, GB Frost, EV Efimova, D Wu, DJ Wolfgeher, ...
Cell chemical biology 29 (10), 1517-1531. e7, 2022
62022
3-methylideneoxan-4-one compounds and substituted derivatives thereof as inhibitors of telomerase
KA Scheidt, RC Betori
US Patent 11,518,750, 2022
32022
Substituted chromanes, analogs thereof, and methods of use and synthesis
KA Scheidt, RC Betori, BR McDonald
US Patent App. 18/187,380, 2023
2023
Retraction of “Reductive Arylation of Arylidene Malonates Using Photoredox Catalysis”
RC Betori, KA Scheidt
ACS Catalysis 13 (19), 12848-12848, 2023
2023
Substituted chromanes, analogs thereof, and methods of use and synthesis
KA Scheidt, RC Betori, BR McDonald
US Patent 11,639,340, 2023
2023
3-Methylideneoxan-4-One Compounds and Substituted Derivates Thereof as Inhibitors of Telomerase
KA Scheidt, RC Betori
US Patent App. 17/965,352, 2023
2023
Abstract PO-020: Telomerase reverse transcriptase inhibitor NU-1 enhances radiation and chemotherapy sensitivity by disrupting DNA repair and accelerating cellular senescence
Y Liu, SJ Kron, RC Betori, KA Scheidt, G Frost, D Wu, DJ Wolfgeher, ...
Clinical Cancer Research 27 (8_Supplement), PO-020-PO-020, 2021
2021
Telomerase reverse transcriptase inhibitor NU-1 enhances radiation and chemotherapy sensitivity by disrupting DNA repair and accelerating cellular senescence.
Y Liu, SJ Kron, RC Betori, KA Scheidt, G Frost, D Wu, DJ Wolfgeher, ...
CLINICAL CANCER RESEARCH 27 (8), 2021
2021
Correction: Reductive annulations of arylidene malonates with unsaturated electrophiles using photoredox/Lewis acid cooperative catalysis
RC Betori, BR McDonald, KA Scheidt
Chemical Science 12 (15), 5688-5688, 2021
2021
Natural-Product-Inspired Covalent Telomerase Inhibitors
D Trauner, C Fischer
Synfacts 16 (05), 0597, 2020
2020
The system can't perform the operation now. Try again later.
Articles 1–20